Paul Bisaro - 31 Oct 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Justin Hunter For: Paul Bisaro
Issuer symbol
MYGN
Transactions as of
31 Oct 2022
Net transactions value
$0
Form type
4
Filing time
01 Nov 2022, 16:31:18 UTC
Previous filing
03 Oct 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +16,875 $0.000000 16,875 31 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.